Infections, Gram-positive Bacterial
2 clinical trials · Condition
◉ Watch Infections, Gram-positive Bacterial
| Record | Firm | Date |
|---|---|---|
| Phase 2 Trial of TD-6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI) (NCT00077675) | Cumberland Pharmaceuticals | 2004-02-01 |
| Phase 2 Trial of TD 6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI) (NCT00061633) | Cumberland Pharmaceuticals | 2003-06-01 |
Track Infections, Gram-positive Bacterial automatically
Every clearance here is in the API, with alerts when new ones post.